Snowball logo
logo
GALD

Galderma Group N

GALD SW
Fr153.40+Fr3.70  (2.47%)

Frequently asked questions

What sector does Galderma Group N (GALD) operate in?

Galderma Group N belongs to the Other sector and operates in the Drug Manufacturers - Specialty & Generic industry.

What is Galderma Group N (GALD) current stock price?

As of the latest data, Galderma Group N stock price is CHF 153.40, with a previous close of CHF 149.70. Galderma Group N gained CHF 3.70 in the last trading session, representing a 2.47% increase.

What is Galderma Group N (GALD) current market capitalization?

Galderma Group N market cap is approximately 35.98 billion.

What is Galderma Group N (GALD) Earnings Per Share (EPS)?

The trailing EPS is CHF 2.05, and the forward EPS is CHF 6.17.

What is Galderma Group N (GALD) Price-to-Earnings (P/E) ratio?

Galderma Group N current P/E ratio is 74.83, with a forward P/E of 24.86.

What is Galderma Group N (GALD) EBITDA?

Galderma Group N EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is 438.27 million.

Does Galderma Group N (GALD) pay dividends?

Yes. Galderma Group N pays annual dividends with an annualized yield of 0.1% and an estimated annual payout of CHF 0.15 per share.

When is the next ex-dividend date for Galderma Group N (GALD)?

The next ex-dividend date is scheduled for April 25, 2026.

When is Galderma Group N (GALD) next earnings report?

Galderma Group N is expected to release its next earnings report on December 31, 2025.

What is Galderma Group N (GALD) beta (volatility) score?

Galderma Group N has a beta of 0.338, indicating lower volatility than the overall market.